Skip to main content
. 2023 Apr 6;13:1043244. doi: 10.3389/fonc.2023.1043244

Figure 2.

Figure 2

Conversion of chest computed tomography at different times. (A and a) Baseline findings on chest computed tomography (tumor size: 52 × 55 mm). (B and b) The mass shrank significantly (tumor size: 31 × 18 mm) after treatment with four cycles of anlotinib plus cisplatin. (C and c) Stable disease (tumor size: 25 × 21 mm) following 12 cycles of anlotinib + tegafur. (D and d) Progressive disease (tumor size: 41 × 34 mm) after 29 cycles of anlotinib + tegafur.